Merril Pharma Private Limited, a active private limited company, was established on 22 August 2005 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PTC046638. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.73 M and a paid-up capital of ₹4.01 M.
It upholds a compliant status. Employing 157 professional, Its leadership includes Jitendrakumar Raval (Director), Rajendrasingh Jodha (Director), Rajendrakumar Patel (Director). It holds ₹17.81 Cr open charges and ₹16.18 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A.402, Empire Business Hub, Opp, Shakti Farm, Science City Road, Sola,, Ahmedabad, Gujarat, 380060.
U24230GJ2005PTC046638
046638
22 August 2005
₹5.73 M
₹4.01 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Merril Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendrakumar Raval | Director | 15 May 2006 | Current |
| Rajendrasingh Jodha | Director | 22 Aug 2005 | Current |
| Rajendrakumar Patel | Director | 15 May 2006 | Current |
| Bharatkumar Patel | Director | 22 Aug 2005 | Current |
| Vipulkumar Bharatbhai Patel | Director | 29 Jun 2007 | Current |
| Rakeshkumar Patel | Director | 15 May 2006 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Merril Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 30.58% increase. The company also saw a substantial improvement in profitability, with a 68.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Merril Pharma had a promoter holding of 78.80% and a public holding of 21.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹178,121,000.00
₹161,774,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2025 | Others | ₹0.10 M | Open |
| 29 Jan 2025 | Others | ₹5.20 Cr | Open |
| 29 Jan 2025 | Others | ₹4.79 Cr | Open |
| 23 Mar 2022 | Sidbi | ₹8.99 M | Open |
| 29 Jul 2020 | Sidbi | ₹3.00 Cr | Open |
Explore comprehensive loan charge details -
Merril Pharma has a workforce of 157 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Merril Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merril Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Merril Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 0.10 M with Charge ID 101090378 was registered on 05 May 2025. was recorded as a recent event.
A charge with Others of Rs. 51.96 M registered on 29 Jan 2025 with Charge ID 101054608 was modified on 24 Apr 2025. was recorded as a recent event.
A charge with Others of Rs. 47.90 M registered on 29 Jan 2025 with Charge ID 101054471 was modified on 24 Apr 2025. was recorded as a recent event.
Merril Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
A charge registered on 18 Dec 2020 via Charge ID 100399332 with Bank Of India was fully satisfied on 18 Feb 2025. was recorded as a recent event.
The CIN of Merril Pharma Private Limited is U24230GJ2005PTC046638.
Merril Pharma Private Limited is headquartered at A.402, Empire Business Hub, Opp, Shakti Farm, Science City Road, Sola,, Ahmedabad, Gujarat, 380060.
Merril Pharma Private Limited was incorporated on 22 August 2005.
The current directors of Merril Pharma Private Limited are
The primary industry of Merril Pharma Private Limited is Manufacturing.
Merril Pharma Private Limited is unlisted.
The authorized capital of Merril Pharma Private Limited is ₹5.73 M, and the paid-up capital is ₹4.01 M.
The compliance status of Merril Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX